School of Medicine

Washington University is expanding access to MO/Notify, a smartphone system that privately sends pop-up alerts to users in Missouri when they have spent time near someone who later tests positive for COVID-19.

Jonathan Kipnis, a professor and a BJC Investigator at the School of Medicine, has been named an academic editor of the Journal of Experimental Medicine.

Researchers at Washington University School of Medicine have discovered a molecule in the lungs of tuberculosis (TB) patients that reflects the levels of TB-causing bacteria in the lungs. The findings may represent a step toward more tailored treatment regimens and better patient outcomes.

New research from Washington University School of Medicine has solved the medical mystery of why a 2-year-old child — seemingly healthy at birth — succumbed to an undiagnosed rare illness.

The IpsiHand, an innovative stroke-recovery device developed by a WashU startup that helps stroke patients recover arm and hand function by retraining their brains, has received the 2021 Pantheon Product of the Year Award from California Life Sciences.

A home-based health monitoring program developed by Washington University School of Medicine and BJC HealthCare has proven invaluable in helping to track the progress of patients who test positive for the virus but aren’t sick enough to be hospitalized.

Graham Colditz and Su-Hsin Chang, both at the School of Medicine, received a five-year $3.2 million grant from the National Cancer Institute of the National Institutes of Health (NIH) for multiple myeloma research.

Eight faculty members at Washington University are among 564 new fellows selected by the American Association for the Advancement of Science: Leonard Green, Elizabeth S. Haswell, Sophia E. Hayes, Erik Herzog, Mark A. McDaniel, Jay W. Ponder, Crickette Sanz and Pamela K. Woodard.

Sabin Nettles, a graduate student at the School of Medicine, received the Pre/Postdoctoral Next Generation Award from the Society for Neuroscience in recognition of her work introducing neuroscience to young students through the Brain Discovery initiative. 

Washington University School of Medicine is part of a major international study aimed at identifying causes and effects of the early stages of schizophrenia in young people, with the goal of improving early diagnosis and treatment. Daniel Mamah, MD, is the lead investigator at the WashU site.